The classical understanding of personal autonomy, which still influences medical guidelines, is based on an individualistic framework and is inadequate for ethical mental health care. The goal of ...

Medifast's strong quarterly performance, investments in growth strategies, and undervalued stock make it an attractive ...

Fintel reports that on November 5, 2024, DA Davidson upgraded their outlook for Medifast (NYSE:MED) from Underperform to ...

Q3 2024 Earnings Call Transcript November 4, 2024 Medifast, Inc. beats earnings expectations. Reported EPS is $0.1029, ...

DA Davidson analyst Linda Bolton Weiser upgraded Medifast (MED) to Neutral from Underperform with a price target of $17, up from $16.50. With ...

Medifast ( (MED) ) has released its Q3 earnings. Here is a breakdown of the information Medifast presented to its investors. Medifast (NYSE: ...

For the current quarter ending in December, Medifast expects its per-share earnings to range from 10 cents to 65 cents. The company said it expects revenue in the range of $100 million to $120 million ...

Wellness company Medifast (NYSE:MED) will be reporting results tomorrow after market hours. Here’s what investors should know. Medifast missed analysts’ revenue expectations by 3.2% last quarter, ...

Wellness company Medifast (NYSE:MED) will be reporting results tomorrow after market hours. Here’s what investors should know. Medifast missed analysts’ revenue expectations by 3.2% last ...

Medifast, Inc. MED is likely to register a decrease in both top and bottom lines when it reports third-quarter 2024 earnings on Nov. 4. The Zacks Consensus Estimate for revenues is pegged at $135. ...